Navigating the Future: Gene Therapy Clinical Trial Services Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Gene Therapy Clinical Trial Services Market Size Growth Forecast: What to Expect by 2025?
In previous years, the gene therapy clinical trial services market has seen a rapid expansion. It is projected to increase from $1.53 billion in 2024 to $1.82 billion in 2025, showing a compound annual growth rate (CAGR) of 19.6%. The growth witnessed in the historic period is due to factors such as increased investment in research and development, a higher incidence of rare genetic diseases, a growing preference for precision medicine methods, enhanced regulatory backing via fast-track approval routes, and an increasing count of gene therapy candidates.

How Will the Gene Therapy Clinical Trial Services Market Size Evolve and Grow by 2029?
The market for gene therapy clinical trial services is projected to experience accelerated growth over the upcoming years, escalating to a value of $3.69 billion by 2029, with a compound annual growth rate (CAGR) of 19.2%. This expansion during the forecast era is owed to advancements in gene-editing technologies, an increase in the number of clinical trials, heightened demand for individualized therapies, surging investment for cell and gene therapy manufacturing infrastructure, and intensification of patient acquisition endeavors. Trends expected to make the most significant impact throughout this period correspond to improvements in gene-editing capabilities and vector manufacturing, advancements in patient recruitment approaches, the utilization of real-world evidence, and the adoption of decentralized trial models.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gene-therapy-clinical-trial-services-global-market-report

What Drivers Are Propelling the Growth of Gene Therapy Clinical Trial Services Market Forward?
The surging need for tailor-made healthcare is anticipated to boost the gene therapy clinical trial services market's expansion. Personalized medicine is a strategy in healthcare that customizes treatments based on individual attributes such as genetic details, biomarker information, and lifestyle habits. The demand for this form of medicine is spurred by advancements in genomics and biotechnology, allowing for more accurate therapy targeting. Through patient-specific genetic profile analysis, gene therapy clinical trial services facilitate personalized medicine, designing treatments to enhance safety and efficiency using biomarker analysis and companion diagnostics. To exemplify, per the data from the Personalized Medicine Coalition, a hospital and healthcare organization based in the US, the FDA approved 16 unique personalized treatments for rare disease patients in 2023, in contrast with six in 2022 as an example of its applications. Consequently, the escalating demand for personalized medicine is a key driver in boosting the growth of the gene therapy clinical trial services market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27292&type=smp

What Are the Key Trends Driving Gene Therapy Clinical Trial Services Market Growth?
Leading firms in the gene therapy clinical trial services market are channeling their efforts into the creation of innovative solutions such as the Long-Term Follow-Up (LTFU) model for cell and gene therapy (CGT) trials. This aims to speed up the entire trial process while adhering to regulatory standards and safety measures. The LTFU model for CGT trials is a meticulously planned structure in place to supervise patients for a prolonged period, usually as long as 15 years post receiving a CGT treatment. For example, Medable Inc., an American SaaS enterprise, introduced a digitally advanced LTFU model specifically crafted for CGT trials in May 2025. This model aids CGT trials by lessening patient and site challenges, all the while maintaining scientific integrity throughout the FDA-mandated 15-year supervision period. It enhances patient reach, retention, and consistent data flow via remote and hybrid follow-up methods, thereby improving long-term safety and efficacy supervision.

What Are the Key Segments in the Gene Therapy Clinical Trial Services Market?
The gene therapy clinical trial services market covered in this report is segmented

1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types
2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)

Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design
2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage
3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring
4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling
5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits
6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27292&type=smp

Who Are the Key Players Shaping the Gene Therapy Clinical Trial Services Market's Competitive Landscape?
Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Poseida Therapeutics Inc., Veristat LLC, Genprex Inc., Novotech Health Holdings Pte Limited, bluebird bio Inc.

What Geographic Markets Are Powering Growth in the Gene Therapy Clinical Trial Services Market?
North America was the largest region in the gene therapy clinical trial services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27292

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.